These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7909750)

  • 1. Neuromuscular block by vecuronium: simulation with a flow-volume model.
    Nigrovic V
    Eur J Anaesthesiol; 1994 Mar; 11(2):65-74. PubMed ID: 7909750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of corticosteroids on the recovery from vecuronium induced block].
    Shima H
    Masui; 1990 May; 39(5):619-25. PubMed ID: 1974654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular blocking action of vecuronium in the dog and its reversal by neostigmine.
    Jones RS
    Res Vet Sci; 1985 Mar; 38(2):193-6. PubMed ID: 2860709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A pharmacodynamic analysis of the onset of neuromuscular blockade by nondepolarizing muscle relaxants--the pharmacodynamics of a large dose of vecuronium].
    Yajima C; Sugai N; Hanaoka K; Numata K
    Masui; 1990 Jan; 39(1):2-7. PubMed ID: 1968108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rate of injection on the neuromuscular block produced by vecuronium.
    Feldman SA; Soni N; Kraayenbrink MA
    Anesth Analg; 1989 Nov; 69(5):624-6. PubMed ID: 2572184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experiences with vecuronium in children.
    De MP; Paul AK
    J Indian Med Assoc; 1991 May; 89(5):125-7. PubMed ID: 1684200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between vecuronium and suxamethonium in the dog.
    Jones RS
    Res Vet Sci; 1986 Jul; 41(1):93-7. PubMed ID: 2876469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of body fat on the onset of vecuronium induced neuromuscular blockade.
    Takaya T; Takeyama K; Miura M; Takiguchi M
    Tokai J Exp Clin Med; 2001 Oct; 26(3):107-11. PubMed ID: 11885752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive closed-loop feedback control of vecuronium-induced neuromuscular relaxation.
    Olkkola KT; Schwilden H
    Eur J Anaesthesiol; 1991 Jan; 8(1):7-12. PubMed ID: 1678702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent paralysis in critically ill patients after long-term administration of vecuronium.
    Segredo V; Caldwell JE; Matthay MA; Sharma ML; Gruenke LD; Miller RD
    N Engl J Med; 1992 Aug; 327(8):524-8. PubMed ID: 1353252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers.
    Caldwell JE; Szenohradszky J; Segredo V; Wright PM; McLoughlin C; Sharma ML; Gruenke LD; Fisher DM; Miller RD
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1216-22. PubMed ID: 7932174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between twitch depression and twitch fade during neuromuscular block produced by vecuronium: correlation with the release of acetylcholine.
    Bhatt SB; Kohl J; Amann A; Nigrovic V
    Theor Biol Med Model; 2007 Jul; 4():24. PubMed ID: 17634128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative characteristics of atracurium and vecuronium. A simultaneous clinical and pharmacokinetic study.
    Wright PM; Hart P; Lau M; Sharma ML; Gruenke L; Fisher DM
    Anesthesiology; 1994 Jul; 81(1):59-68; discussion 27A. PubMed ID: 7913801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Context-sensitive recovery of neuromuscular function from vecuronium in dogs: Effects of dose and dosing protocol.
    Lorenzutti AM; Zarazaga MP; Sakai DM; Nejamkin P; Rosetti V; Duran V; Martin-Flores M
    Vet J; 2019 Jun; 248():14-17. PubMed ID: 31113556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and pharmacodynamics of vecuronium in children].
    Steinbereithner K; Fitzal S; Schwarz S; Gilly H; Semsroth M; Weindlmayr-Goettel M
    Cah Anesthesiol; 1984; 32(1):5-10. PubMed ID: 6152193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Onset time and duration of action of neuromuscular block induced by increasing doses of vecuronium bromide].
    Russo R; Veschi G; Dellino E; Ciceri R; Iapichino G
    Minerva Anestesiol; 1993; 59(1-2):35-8. PubMed ID: 8097304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of succinylcholine on neuromuscular transmission during recovery from vecuronium].
    Miyamoto M; Hirai H; Fujimoto K; Yurino M; Ogawa H
    Masui; 1994 Apr; 43(4):487-91. PubMed ID: 7910644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
    Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of neuromuscular blocking effect of vecuronium by antibiotics.
    Jedeikin R; Dolgunski E; Kaplan R; Hoffman S
    Anaesthesia; 1987 Aug; 42(8):858-60. PubMed ID: 2889390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differences in the neuromuscular blockade of the larynx and thenar muscles following relaxation with vecuronium].
    Streinzer W; Gilly H; Redl G; Draxler V; Zrunek M; Höfler H
    Laryngol Rhinol Otol (Stuttg); 1986 Nov; 65(11):628-31. PubMed ID: 2880269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.